NxR Biotechnologies GmbH Switzerland

NxR Biotechnologies is a boutique global consulting firm assisting life science companies and academic institutions conduct business development or investment initiatives. Particularly, NxR provides services for performing strategic, scientific, and commercial assessments; writing business plans; gathering competitive intelligence; and implementing entrepreneurship projects, partnership and in/out-licensing of conventional or regenerative medicine products, and commercialization deals. Areas of focus encompass the pharmaceutical industry and the white biotechnology industry. In the pharmaceutical industry, NxR focuses on cell-based and gene-based therapeutics, nucleic acid therapeutics, and biologics, in oncology, neurodegenerative diseases, inflammation, and rare diseases. In the white biotechnology industry, areas of specialization comprise sustainable chemicals including biomass conversion, biofuels, and polymers, as well as high value-added fermentation products including amino acids, proteins, and pharmaceuticals. NxR's track record comprises projects with big pharmas, biotechs, generics companies, financial investors, CROs, academia, and start-ups.
Year of foundation
2011
Headquartner in China
Plan in China
partnering
Biotech/Pharma Category
Alain VERTES
Managing Director 
Functionality

Olympus Singapore

Olympus was founded in 1919 and launched our first gastro-camera in the 1950s. Since then, Olympus developed into a MedTech leader, designing and delivering innovative solutions for medical and surgical procedures, especially in the field of endoscopy.
Please specify your partnering goal
Develop the next breakthrough that will shape the future of healthcare
Headquartner in China
Felicia Chung
APAC Region Business Development Lead 
Functionality

Opera CRO, a TIGERMED company Romania

Opera CRO is an international contract research organization (CRO) with offices in Italy (Genoa), in Switzerland (Geneva) and in Romania (Timisoara) that has been managing clinical trials since 1995. In particular, we performed several clinical studies with medical devices, medical drugs and food supplements in many different therapeutic areas.

We offer the possibility of conducting clinical trials in different countries in Eastern Europe, with reduced costs and faster times, or in other European and non-European countries (Italy, France, Switzerland, Germany etc..). Additionally, we offer specific support for the compliance of medical device registrations of the CE marking to the new European regulation. Recently, Opera CRO was acquired by the Tigermed group, the largest CRO in Asia with over 5000 employees and 100 offices. This partnership offers the opportunity to perform clinical trials in China and in the rest of Asia and access that vast market.
The list of our current studies can be found on ClinicalTrial.gov (specifying Opera CRO for Europe, Tigermed for Asia); further information is available on our website: www.operacro.com.
Website:
www.operacro.com
Headquartner in China
Simone Guadagna
Dr 
Functionality

Petrone Group Asia Pacific Pte Ltd Singapore

We are Petrone Group Asia Pacific , a Petrone Group ( www.petrone.it ) sister company dedicated to Global Comparators sourcing for clinical trials to China and APAC region.

We give support to Sponsors , CROs , Clinical Research Institutes , Pharma and Biotech company for IMP management and Comparators sourcing.

Our service has high flexibility in managing clinical trials from phase I to phase IV according to customers’ specific requirements.

To have a better idea of our Global sourcing capabilities please find below a recap of Petrone Group Headquarters and branches

HQ Italy
Euromed , Italian comparator drugs

EU Branches
BCN FARMA Spain / Spanish comparator drugs
PHD Pharmaceuticals / Irish and EU comparator drugs

US Branch
Euromed Pharma NY / US and Canada comparator drugs

Asia Pacific Branch
Petrone Group Asia Pacific Singapore / Asia Pacific and Australia comparator drugs
Website:
www.petrone.it
Company Size (Fulltime employees)
Year of foundation
1960
Please specify your partnering goal
Sourcing comparator drugs to spinsor / biotech / CRO's company in China and APAC
Headquartner in China
Plan in China
Sourcing comparator drugs to sponsor / biotech / CRO's company in China We already supply more than 20 companies in China with bioequivalece test drugs.
Norberto Pandolfi
Managing Director 
Functionality

PHASTAR Japan

PHASTAR is a global biometrics CRO offering statistical consulting, clinical trial reporting, data management and data science services by providing expert consultants and managing and delivering in-house projects, FSP-style arrangements and preferred partnerships.

Our number one priority is ensuring on time, quality work: every project undertaken is supervised on methodology and utilizes internal processes designed to guarantee optimal quality, inspired by 3,700 years accumulated technical experience across the company.

PHASTAR is headquartered in London (UK) and North Carolina (US) and has 12 offices across five continents.
Company Size (Fulltime employees)
Year of foundation
2007
Headquartner in China
Plan in China
PHASTAR plans to open an office in China in Q1 2020.
Your Service Name
Biometrics support
Service Description
Statistics consulting, Clinical trial reporting, Data management and Data science
Target Client Type
Pharmaceutical and biotechnology companies either planning or running clinical trials
Edward Clark
Director 
Functionality

PhysioCue United States

PhysioCue is digital health and therapy device development company, located in the heart of Silicon Valley, California. PhysioCue has developed the thermal neurostimulation technology for a non-invasive hypertension therapy device and a migraine and headache therapy device and migraine and headache pain monitoring mobile app. Using our device once daily for 5-minute treatments gradually elongated the reduced blood pressure. PhysioCue's therapy devices are efficient, safe, easy to use, and has none of the side effects associated with drugs. We have manufactured our devices and delivered devices to our potential partners and users. We've received positive feedback from many people who have tried and liked our devices. PhysioCue devices can help people and save lives.
Company Size (Fulltime employees)
Year of foundation
2013
Funding Status
PhysioCue is seeking to raise $7M for a syndicate in our Series A round of financing.
Headquartner in China
Plan in China
Set up a JV in China and looking for a distribution partner.
Simon Yi
LinkedIn logo President 
Functionality

Ping Rawson United States

Dyadic International, Inc. is a global biotechnology company focused on improving and applying its proprietary C1 gene expression platform, based on a patented and proprietary genetically modified strain of the fungus Thermothelomyces heterothallica (formerly Myceliophthora thermophila), to address opportunities in the human and animal health markets. C1 is a potentially game-changing biopharmaceutical gene expression platform that may help bring biologic vaccines, drugs and other biologic products to market faster and more efficiently than existing expression platforms, such as Chinese hamster ovary (CHO) cells, E. coli, yeast and baculovirus in greater volumes, at lower cost and with new properties that can improve access and cost to patients and the healthcare system.

Year of foundation
1979
Headquartner in China
Plan in China
Looking for business partners and collaborations in China.
Biotech/Pharma Asset Stage
Ping Rawson CFO 
Functionality

PRECURE Denmark

Imagine a world without Musculoskeletal Disorders (MSD) like back pain and tennis elbow!

This is the vision of PRECURE! 80 million people in the EU suffer from MSD, leading to €39 billion in employer costs, and more than €80 billion in societal costs. PRECURE provide an integrated solution for insurers and companies to help prevent MSD, reduce costs and create healthier workplaces. Our smart wearables measure employees physical activities throughout the workday. The data helps the employee reduce the muscle load, enables the company to remove the causes, and for the insurer to reduce claims. This is win for the individual, employer, insurer, and society.
Company Size (Fulltime employees)
Year of foundation
2016
Please specify your partnering goal
Healthcare / workers´ compensation insurance partner or strategic partner, who would be interested in market our solution
Funding Status
Seed
Now raising (In USD)
2000000
Headquartner in China
Plan in China
Find healthcare / workers´ compensation insurance partner, strategic partner or large company, who would be interested in pilotting and later market our solution in China.
Mr. Finn Bech Andersen
LinkedIn logo CEO 
Functionality

PreOmics Germany

The founder team of PreOmics started working on optimized LC-MS proteomic workflows at the Matthias Mann lab in 2010. After establishing an optimized and easier sample preparation process in 2014, Dr. Nils A. Kulak together with Dr. Garwin Pichler set forth to validate their technologies with external laboratories and researchers. With a lot of support of proteomics experts, engineers and industry designers, they made their first product ready-for-market. The PreOmics team won several awards for their business idea, were supported by various accelerator programs and established their company in the beginning of 2016. They are now located at the IZB in Martinsried just south of Munich.
We empower our clients in life science to establish biological knowledge through efficient reliable solutions and workflows that set the standard for protein analysis. Our team spirit, energy and commitment empower us to be creative and quality focused. A trusted partner with deeply rooted scientific experience.
Website:
www.preomics.com
Company Size (Fulltime employees)
Year of foundation
2016
Please specify your partnering goal
We are looking for potential customers in China
Headquartner in China
Plan in China
We see high potential of our technologies in the stark growing market for mass spectrometry based protein analyses in China.
Biotech/Pharma Asset Stage
Medtech Development Stage
Garwin Pichler
CEO 
Functionality

REM Analytics SA Switzerland

REM Analytics is a research and development service organisation, helping our customers develop and commercialise new products fast.
Having developed a series of core proprietary technologies, we deploy them to guarantee our customers the shortest time from concept to market. Our areas of focus are the development of personalised nutrition solutions, active food ingredients, functional cosmetics and agriculture.
Year of foundation
2020
Please specify your partnering goal
Identifying partners to jointly develop new products and services
Headquartner in China
Plan in China
Our goal is to identify innovation driven companies with whom to partner for joint development projects.
Assets Information 1: Name|Description|Indications|Stage|IP countries
ATGC|Microbniome analysis platform||Deployed and functioning|
Assets Information 2
ACIMA|Advanced Clinical data acquisition platform|Personalised medicine|Prototype test in progress|
Paulo Refinetti
Dr. 
Functionality